Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,265,926
-$3,726,446 QoQ
Shares Held
10,020
-72.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#979
of 2,266 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MIROVA holds $45,598,850 across 5 Drug Manufacturers - General names. GILD ranks #4 (2.8% of the industry book) .
All Filings in GILD
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,265,926 | 10,020 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,992,372 | 35,821 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $457,083 | 3,724 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $447,885 | 4,035 | Shares | Defined | 2025-12-29 | |
| 2025-06-30 | $447,360 | 4,035 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $324,384 | 2,895 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $3,373,050 | 40,232 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,760,317 | 40,232 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,946,994 | 40,232 | Shares | Defined | 2024-05-13 | |
| 2023-06-30 | $167,087 | 2,168 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $479,483 | 5,779 | Shares | Defined | 2023-05-12 | |
| 2021-09-30 | $326,129 | 4,669 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $293,137 | 4,257 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $275,129 | 4,257 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,090,568 | 18,719 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $993,030 | 15,715 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,211,266 | 15,743 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $932,855 | 12,478 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||